Citadel Advisors’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-118,652
| Closed | -$82.9K | – | 6750 |
|
|
2023
Q1 | $82.9K | Sell |
118,652
-492,555
| -81% | -$344K | ﹤0.01% | 4984 |
|
|
2022
Q4 | $501K | Sell |
611,207
-780,029
| -56% | -$640K | ﹤0.01% | 3843 |
|
|
2022
Q3 | $1.45M | Buy |
1,391,236
+11,890
| +0.9% | +$12.4K | ﹤0.01% | 3056 |
|
|
2022
Q2 | $2.26M | Sell |
1,379,346
-25,870
| -2% | -$42.4K | ﹤0.01% | 2620 |
|
|
2022
Q1 | $4.13M | Sell |
1,405,216
-36,820
| -3% | -$108K | ﹤0.01% | 2243 |
|
|
2021
Q4 | $6.89M | Sell |
1,442,036
-15,607
| -1% | -$74.6K | ﹤0.01% | 1820 |
|
|
2021
Q3 | $11M | Sell |
1,457,643
-343,445
| -19% | -$2.6M | ﹤0.01% | 1356 |
|
|
2021
Q2 | $13.4M | Buy |
1,801,088
+855,239
| +90% | +$6.38M | ﹤0.01% | 1221 |
|
|
2021
Q1 | $7.38M | Buy |
945,849
+887,474
| +1,520% | +$6.92M | ﹤0.01% | 1691 |
|
|
2020
Q4 | $539K | Buy |
+58,375
| New | +$539K | ﹤0.01% | 3790 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5455 |
|
|
2020
Q2 | – | Sell |
-282,130
| Closed | -$528K | – | 5462 |
|
|
2020
Q1 | $528K | Sell |
282,130
-1,465
| -0.5% | -$2.74K | ﹤0.01% | 3357 |
|
|
2019
Q4 | $533K | Buy |
283,595
+941
| +0.3% | +$1.77K | ﹤0.01% | 3496 |
|
|
2019
Q3 | $402K | Sell |
282,654
-14,467
| -5% | -$20.6K | ﹤0.01% | 3644 |
|
|
2019
Q2 | $838K | Sell |
297,121
-151,712
| -34% | -$428K | ﹤0.01% | 3125 |
|
|
2019
Q1 | $2.14M | Sell |
448,833
-245,961
| -35% | -$1.17M | ﹤0.01% | 2266 |
|
|
2018
Q4 | $2.95M | Sell |
694,794
-363,458
| -34% | -$1.54M | ﹤0.01% | 1881 |
|
|
2018
Q3 | $11.6M | Buy |
1,058,252
+192,533
| +22% | +$2.11M | 0.01% | 1027 |
|
|
2018
Q2 | $14.1M | Buy |
+865,719
| New | +$14.1M | 0.01% | 865 |
|